Balchem(US:BCPC)2025-04-24 22:53Financial Performance - Balchem's 2024 sales reached $954 million[9] - The company's 2024 adjusted EBITDA was $250 million, with a margin of 26.3%[12] - In Q1 2025, sales grew by 4.5% to $250.5 million from $239.7 million in Q1 2024[57] - Adjusted EBITDA for Q1 2025 increased by 8.9% to $66.3 million compared to $60.9 million in Q1 2024[59] - Adjusted net earnings for Q1 2025 rose by 19.2% to $40.0 million from $33.6 million in Q1 2024[61] - Adjusted EPS for Q1 2025 grew by 18.4% to $1.22 per share from $1.03 per share in Q1 2024[63] Business Segments - Human Nutrition & Health accounted for 63% of Balchem's 2024 revenue[15] - Animal Nutrition & Health contributed 23% to the company's 2024 revenue[15] - Specialty Products represented 14% of Balchem's 2024 revenue[15] Sustainability - Balchem reached 1.2 billion people in 2024 through its products[86] - The company has reduced its Scope 1 and 2 GHG emissions by 32%, surpassing its 2030 goal[91] - Balchem has reduced its water withdrawal by 15% from the baseline and is on track to meet its 2030 goal[93]